← 產業報告目錄
Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others), By Therapy, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-12頁數 179報告編號 INSIGHTACE-705a36d581
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Maternal Mental Health Market stood at USD 9.88 Bn in 2024, and is expected to reach USD 100.38 Bn by 2034, recording a CAGR of 26.2% from 2025 through 2034.
Maternal Mental Health encompasses The maternal mental health market represents a subset of the healthcare business that focuses on diagnosing, treating, and preventing mental health disorders in pregnant women and new mothers. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Market momentum is underpinned by mounting appetite for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, underpinned by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Maternal Mental Health Market Snapshot
Chapter 4. Global Maternal Mental Health Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Disease indication Estimates & Trend Analysis
5.1. By Disease indication, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease indication:
5.2.1. Postpartum Depression
5.2.2. Dysthymia
5.2.3. Pregnancy and Postpartum General Anxiety
5.2.4. Pregnancy and Postpartum OCD
5.2.5. Birth-Related PTSD
5.2.6. Others
Chapter 6. Market Segmentation 2: By Therapy Estimates & Trend Analysis
6.1. By Therapy & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapy:
6.2.1. Antidepressants
6.2.1.1. Selective serotonin reuptake inhibitors (SSRIs)
6.2.1.2. Tricyclic antidepressants (TCAs)
6.2.1.3. Others
6.2.2. Interpersonal Psychotherapy (IPT)
6.2.3. Cognitive Behavioral Therapy (CBT)
6.2.4. Others
Chapter 7. Maternal Mental Health Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Maternal Mental Health Market revenue (US$ Million) estimates and forecasts By Disease indication, 2021-2034
7.1.2. North America Maternal Mental Health Market revenue (US$ Million) estimates and forecasts By Therapy, 2021-2034
7.1.3. North America Maternal Mental Health Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Maternal Mental Health Market revenue (US$ Million) By Disease indication, 2021-2034
7.2.2. Europe Maternal Mental Health Market revenue (US$ Million) By Therapy, 2021-2034
7.2.3. Europe Maternal Mental Health Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Maternal Mental Health Market revenue (US$ Million) By Disease indication, 2021-2034
7.3.2. Asia Pacific Maternal Mental Health Market revenue (US$ Million) By Therapy, 2021-2034
7.3.3. Asia Pacific Maternal Mental Health Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Maternal Mental Health Market revenue (US$ Million) By Disease indication, (US$ Million) 2021-2034
7.4.2. Latin America Maternal Mental Health Market revenue (US$ Million) By Therapy, (US$ Million) 2021-2034
7.4.3. Latin America Maternal Mental Health Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Maternal Mental Health Market revenue (US$ Million) By Disease indication, (US$ Million) 2021-2034
7.5.2. Middle East & Africa Maternal Mental Health Market revenue (US$ Million) By Therapy, (US$ Million) 2021-2034
7.5.3. Middle East & Africa Maternal Mental Health Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Therapy Mama
8.2.2. Canopie
8.2.3. Pfizer Inc
8.2.4. Viatris Inc.
8.2.5. GlaxoSmithKline Inc.
8.2.6. Alembic Pharmaceuticals Limited
8.2.7. Mallinckrodt Inc.
8.2.8. Sage Therapeutics, Inc.
8.2.9. Bausch Health Companies Inc.
8.2.10. Magellan Health, Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們